Roundhill Robotaxi, Autonomous Vehicles and Technology ETF (CABZ)
Live price chart, market sentiment, and community perspectives for Roundhill Robotaxi, Autonomous Vehicles and Technology ETF (CBOE: CABZ).
Live price chart, market sentiment, and community perspectives for Roundhill Robotaxi, Autonomous Vehicles and Technology ETF (CBOE: CABZ).
From a portfolio construction standpoint, CABZ functions best as a satellite allocation rather than a core holding. The asymmetric upside of autonomous mobility is undeniable over a multi-decade horizon, but the path will be marked by severe drawdowns driven by technological bottlenecks and safety incidents. We advise scaling into positions gradually during periods of thematic apathy rather than chasing momentum breakouts.
Options skew in CABZ is leaning heavily bearish into the next rate cycle decision. Watching the 50-day moving average closely for an inflection.
From a structural analysis standpoint, the portfolio construction of CABZ features roughly 32 holdings with a notable 46.1% allocation to foreign issues, including multiple Chinese autonomous vehicle manufacturers and LiDAR suppliers like Baidu, WeRide, Pony AI, and Hesai Group. While this offers targeted geographic distribution across the global AV landscape, it introduces severe regulatory vulnerabilities. The fund's disclosures explicitly flag dependencies on government spending policies, permitting regimes, export controls on critical semiconductors, and geopolitical instability as persistent operational headwinds.
Evaluating the regulatory and legal landscape, the path to nationwide deployment remains fractured state-by-state and city-by-city. Liability frameworks for unsupervised AI decision-making are still untested in many jurisdictions, introducing a persistent regulatory overhang that can instantly halt operations in key testing markets. This legal friction is an unpriced structural tax that must be factored into any long-term discounted cash flow model for the ETF's top holdings.
From a fundamental industry research standpoint, the bottleneck for robotaxis is no longer just machine learning model accuracy; it is the path to unit economic profitability at scale. Hardware suites featuring advanced solid-state lidar, redundant compute units, and thermal management systems carry steep bill-of-materials costs. Monitoring component cost curves is critical to determining which underlying holdings will achieve sustainable free cash flow before burning through current capital reserves.
Watching the technical indicators for CABZ reveals a classic post-launch drift. The stock price sits around $20.31, tracking roughly 1.75% below its 20-day moving average and over 6% below its 50-day moving average. Having touched an all-time low of $19.20 in late March 2026 after a fleeting launch-day peak of $25.33, the 43.4 RSI confirms mild, persistent downward momentum. Furthermore, its 3-month NAV return of -7.18% sharply lags the broader US Fund Technology category average of +10.31%, highlighting significant underperformance during its initial operational window.
Looking at the portfolio from a systemic risk management perspective, the primary danger is correlation convergence during market-wide drawdowns. Autonomous vehicle adoption is heavily dependent on consumer trust and municipal infrastructure spending. In a macro liquidity squeeze, high-duration thematic equities like those held in CABZ tend to experience severe multiple compression, necessitating a robust overlay of macro index puts or managed futures to protect the downside.
Win $5,000 Cash, Amazon & Starbucks eGifts on free signup.
On our desk, CABZ is an absolute non-starter for meaningful allocation right now. With a daily dollar volume hovering around $5,606 and a 0.46% bid-ask spread, a $10,000 retail trade immediately drops nearly $46 into the spread before any market movement. Even though the thematic thesis around robotaxis and autonomous driving is compelling—backed by names like Tesla, Alphabet, and Uber—the fund's tiny AUM of roughly $3.5M and embryonic track record since January 2026 make liquidity risk completely unmanageable for institutional scaling.
Explore plasma cleansing, somatic organ swaps, and BCI.